These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 4435021)

  • 1. Chronic Behavioral and Neurochemical Effects of Four Novel
    Ilyin NP; Nabiullin AD; Kozlova AD; Kupriyanova OV; Shevyrin VA; Gloriozova T; Filimonov D; Lagunin A; Galstyan DS; Kolesnikova TO; Mor MS; Efimova EV; Poroikov V; Yenkoyan KB; de Abreu MS; Demin KA; Kalueff AV
    ACS Chem Neurosci; 2024 May; 15(10):2006-2017. PubMed ID: 38683969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of
    Tirri M; Bilel S; Arfè R; Corli G; Marchetti B; Bernardi T; Boccuto F; Serpelloni G; Botrè F; De-Giorgio F; Golembiowska K; Marti M
    Front Psychiatry; 2022; 13():875722. PubMed ID: 35530025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish.
    Tirri M; Ponzoni L; Bilel S; Arfè R; Braida D; Sala M; Marti M
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32847111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and Bias through Receptor-Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization.
    Fuxe K; Tarakanov A; Romero Fernandez W; Ferraro L; Tanganelli S; Filip M; Agnati LF; Garriga P; Diaz-Cabiale Z; Borroto-Escuela DO
    Front Endocrinol (Lausanne); 2014; 5():71. PubMed ID: 24860548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia.
    Fuxe K; Marcellino D; Woods AS; Giuseppina L; Antonelli T; Ferraro L; Tanganelli S; Agnati LF
    J Neural Transm (Vienna); 2009 Aug; 116(8):923-39. PubMed ID: 19156349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
    Commissaris RL; Rech RH
    Psychopharmacology (Berl); 1982; 76(3):282-5. PubMed ID: 6808551
    [No Abstract]   [Full Text] [Related]  

  • 7. Noradrenergic action of amphetamine following degeneration of descending monoaminergic fibers in the spinal cord.
    Nozaki M; Bell JA; Martin WR
    Psychopharmacology (Berl); 1980 Jan; 67(1):25-9. PubMed ID: 6768076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of amfonelic acid on 5-HT metabolism in rat brain.
    Waldmeier PC; Buchle AM; Stoecklin K; Fehr B; Feldtrauer JJ
    J Neural Transm; 1983; 57(3):149-65. PubMed ID: 6196442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.
    Baker GB; Coutts RT; Rao TS
    Br J Pharmacol; 1987 Oct; 92(2):243-55. PubMed ID: 2890391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.
    Bourgoin S; Artaud F; Bockaert J; Héry F; Glowinski J; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):313-21. PubMed ID: 662027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of para-methoxyamphetamine and 2,5-dimethoxyamphetamine on serotonergic mechanisms.
    Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):101-5. PubMed ID: 581302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hindlimb extensor reflex of spinal rats given tranylcypromine stereoisomers.
    Smith DF
    J Neural Transm; 1979; 44(4):303-7. PubMed ID: 222878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of human prolactin secretion by mescaline.
    Demisch L; Neubauer M
    Psychopharmacology (Berl); 1979 Sep; 64(3):361-3. PubMed ID: 116281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.
    Andén NE; Corrodi H; Fuxe K; Meek JL
    Eur J Pharmacol; 1974 Feb; 25(2):176-84. PubMed ID: 4435021
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
    Glennon RA; Rosecrans JA; Young R
    Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.